equity investment

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – GenoLogics today said that it has raised $8 million in a private round of financing led by Illumina, a new investor in the firm.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Nxt2b has signed an agreement to purchase 49 percent of all outstanding shares of Swedish protein and molecular technologies firm Olink Bioscience for an undisclosed amount.

Westburg already is a distributor for Analytik Jena products.

Biovest is an investment firm led by Innogenetics Co-founder and Chairman Rudi Mariën.

The firms announced a deal to identify strategic investments in technology areas within agriculture "to support and complement Monsanto's interests and potential growth areas."

The UK firm will use the investment to further build partnerships with pharmaceutical and biotech firms and identify novel biomarkers.

Consort's Bespak division also will design disposable test cards that will be part of Atlas' rapid, point-of-care molecular diagnostics system.

The companies also converted roughly $8 million in Calando debt it owed Arrowhead into equity.

CytRx said it sold the shares for $7 million.

Pages

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.